Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 22;14:758915. doi: 10.3389/fnmol.2021.758915

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Zhang, Jin, Xu, Zhang, Guo and Yang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

N-terminal pro-brain natriuretic peptide (NT-proBNP) in poor functional outcome, mortality, hemorrhagic transformation, and early neurologic deterioration. One hundred seventy-seven patients had good functional outcomes and 227 had poor functional outcomes; 30 patients died, 374 survived; 72 patients had hemorrhagic transformation, 332 not; 31 patients had early neurological deterioration, 373 not. Distribution of NT-proBNP was depicted with natural log transformations, which was depicted with median and interquartile range. Patients with poor functional outcome, mortality, and hemorrhagic transformation had higher NT-proBNP levels compared with patients without. *P < 0.05.